2025-524178-40-00已完成1 期
A study to learn more about how safe nurandociguat is and how it affects the way the body processes rosuvastatin and dabigatran in healthy adults
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Bayer AG
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Therapeutic Area Head
Scientific
Bayer AG
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A study to learn how safe nurandociguat is when taken with sildenafil in men with arterial hypertension.Chronic Kidney Disease2025-522336-14-00Bayer AG36
招募中
1 期
(22597) A study to learn about how safe nitroglycerin is and how it affects the body when taken along with nurandociguat in people with coronary artery disease.Chronic kidney disease2025-522335-34-00Bayer AG26
招募中
2 期
A study to investigate the safety and clinical activity of belantamab for the treatment of multiple myeloma when used as monotherapy and in combination treatments.Multiple myeloma2022-501941-63-00Glaxosmithkline Research & Development Limited3
招募中
1 期
A clinical study to investigate the safety, tolerability and pharmacokinetic profile of single ascending concentrations of OPT101 in peritoneal dialysis patients.Chronic kidney disease2025-522966-61-00OPTERION Health AG12
已完成
1 期
Study is designed to assess the safety and tolerability of ceralasertib at increasing doses in combination with other anti-cancer treatment in patients with advanced tumours2023-505006-41-00AstraZeneca AB100